Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data

By Cook C. S.   Berry L. M.   Burton E.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite

A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data

By Rioux Nathalie   Batonga Joëlle   Colombo Federico   Massé Jonathan   Zouki Christine   Ribadeneira Maria D.   Duan Jianmin   Bethell Richard C.  

Xenobiotica, Vol. 43, Iss. 7, 2013-07 ,pp. : 592-597

Informa Healthcare

Access to resources Recommend Favorite

Preclinical and in vitro assessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions

By Mckillop D.   Back D. J.   Mccormick A. D.   Evans J. A.   Tjia J.  

Xenobiotica, Vol. 29, Iss. 4, 1999-04 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers

By Swaisland H. C.   Oliver S. D.   Morris T.   Jones H. K.   Bakhtyari A.   Mackey A.   McCormick A. D.   Slamon D.   Hargreaves J. A.   Millar A.   Taboada M. T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 444-456

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability

By Howgate E. M.   Rowland Yeo K.   Proctor N. J.   Tucker G. T.   Rostami-Hodjegan A.  

Xenobiotica, Vol. 36, Iss. 6, 2006-06 ,pp. : 473-497

Informa Healthcare

Access to resources Recommend Favorite